

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | sulfate transport (GO:0008272) | 9.70391352 |
| 2 | low-density lipoprotein particle clearance (GO:0034383) | 9.36408343 |
| 3 | mesenchymal to epithelial transition involved in metanephros morphogenesis (GO:0003337) | 8.72918878 |
| 4 | regulation of metanephric nephron tubule epithelial cell differentiation (GO:0072307) | 8.63749658 |
| 5 | regulation of mesenchymal to epithelial transition involved in metanephros morphogenesis (GO:0003339 | 8.26991516 |
| 6 | triglyceride catabolic process (GO:0019433) | 7.84704284 |
| 7 | cellular response to gonadotropin stimulus (GO:0071371) | 7.65111931 |
| 8 | nephron tubule formation (GO:0072079) | 7.42649513 |
| 9 | regulation of sequestering of triglyceride (GO:0010889) | 7.26083605 |
| 10 | white fat cell differentiation (GO:0050872) | 7.21903493 |
| 11 | acylglycerol catabolic process (GO:0046464) | 6.99778164 |
| 12 | neutral lipid catabolic process (GO:0046461) | 6.99778164 |
| 13 | positive regulation of hormone metabolic process (GO:0032352) | 6.96538355 |
| 14 | brown fat cell differentiation (GO:0050873) | 6.90032341 |
| 15 | biotin metabolic process (GO:0006768) | 6.57521338 |
| 16 | regulation of apoptotic process involved in morphogenesis (GO:1902337) | 6.55891734 |
| 17 | pattern specification involved in kidney development (GO:0061004) | 6.47728853 |
| 18 | hydrogen peroxide catabolic process (GO:0042744) | 6.25312353 |
| 19 | negative regulation of mesenchymal cell apoptotic process (GO:2001054) | 6.24471386 |
| 20 | valine metabolic process (GO:0006573) | 6.08853520 |
| 21 | triglyceride biosynthetic process (GO:0019432) | 5.72458305 |
| 22 | lipid particle organization (GO:0034389) | 5.54979239 |
| 23 | acylglycerol biosynthetic process (GO:0046463) | 5.51133165 |
| 24 | neutral lipid biosynthetic process (GO:0046460) | 5.51133165 |
| 25 | mesonephros development (GO:0001823) | 5.50773640 |
| 26 | response to dietary excess (GO:0002021) | 5.50175346 |
| 27 | metanephric tubule development (GO:0072170) | 5.48776029 |
| 28 | metanephric nephron tubule development (GO:0072234) | 5.48776029 |
| 29 | urogenital system development (GO:0001655) | 5.45625274 |
| 30 | phenol-containing compound metabolic process (GO:0018958) | 5.38114342 |
| 31 | positive regulation of cellular amine metabolic process (GO:0033240) | 5.37514873 |
| 32 | hormone biosynthetic process (GO:0042446) | 5.33161764 |
| 33 | glycerolipid catabolic process (GO:0046503) | 5.30861614 |
| 34 | regulation of nephron tubule epithelial cell differentiation (GO:0072182) | 5.27261371 |
| 35 | fatty acid transmembrane transport (GO:1902001) | 5.25166849 |
| 36 | positive regulation of fatty acid beta-oxidation (GO:0032000) | 5.20827353 |
| 37 | negative regulation of macrophage derived foam cell differentiation (GO:0010745) | 5.19911980 |
| 38 | positive regulation of fatty acid oxidation (GO:0046321) | 5.16682696 |
| 39 | ovulation from ovarian follicle (GO:0001542) | 5.05490902 |
| 40 | metanephric nephron epithelium development (GO:0072243) | 4.97562860 |
| 41 | negative regulation of microtubule polymerization (GO:0031115) | 4.93027660 |
| 42 | response to gonadotropin (GO:0034698) | 4.92924224 |
| 43 | regulation of cholesterol storage (GO:0010885) | 4.91664278 |
| 44 | regulation of epithelial cell differentiation involved in kidney development (GO:2000696) | 4.90317110 |
| 45 | negative regulation of hormone biosynthetic process (GO:0032353) | 4.72548319 |
| 46 | protein heterotrimerization (GO:0070208) | 4.68915195 |
| 47 | lipid storage (GO:0019915) | 4.68850536 |
| 48 | carnitine shuttle (GO:0006853) | 4.68559879 |
| 49 | regulation of mesenchymal cell apoptotic process (GO:2001053) | 4.65920029 |
| 50 | regulation of stem cell maintenance (GO:2000036) | 4.62217367 |
| 51 | metanephric epithelium development (GO:0072207) | 4.57137126 |
| 52 | long-chain fatty-acyl-CoA metabolic process (GO:0035336) | 4.49660851 |
| 53 | mesenchymal to epithelial transition (GO:0060231) | 4.49060006 |
| 54 | positive regulation of metanephros development (GO:0072216) | 4.46788461 |
| 55 | regulation of hormone metabolic process (GO:0032350) | 4.44138293 |
| 56 | sulfur compound transport (GO:0072348) | 4.38985724 |
| 57 | fatty-acyl-CoA metabolic process (GO:0035337) | 4.37779904 |
| 58 | triglyceride metabolic process (GO:0006641) | 4.35274378 |
| 59 | positive regulation of cellular response to insulin stimulus (GO:1900078) | 4.35121372 |
| 60 | fatty-acyl-CoA biosynthetic process (GO:0046949) | 4.33282538 |
| 61 | long-chain fatty-acyl-CoA biosynthetic process (GO:0035338) | 4.32418342 |
| 62 | fatty acid beta-oxidation (GO:0006635) | 4.30458407 |
| 63 | negative regulation of kidney development (GO:0090185) | 4.27307487 |
| 64 | specification of organ identity (GO:0010092) | 4.25395826 |
| 65 | thioester biosynthetic process (GO:0035384) | 4.23721153 |
| 66 | acyl-CoA biosynthetic process (GO:0071616) | 4.23721153 |
| 67 | regulation of low-density lipoprotein particle receptor biosynthetic process (GO:0045714) | 4.21326063 |
| 68 | positive regulation of glucose import (GO:0046326) | 4.17421361 |
| 69 | branched-chain amino acid metabolic process (GO:0009081) | 4.16514874 |
| 70 | hydrogen peroxide metabolic process (GO:0042743) | 4.13996100 |
| 71 | negative regulation of hormone metabolic process (GO:0032351) | 4.12856306 |
| 72 | acylglycerol metabolic process (GO:0006639) | 4.11882882 |
| 73 | negative regulation of protein autophosphorylation (GO:0031953) | 4.08129888 |
| 74 | neutral lipid metabolic process (GO:0006638) | 4.06792767 |
| 75 | regulation of myelination (GO:0031641) | 4.06390427 |
| 76 | regulation of macrophage derived foam cell differentiation (GO:0010743) | 4.00620249 |
| 77 | thyroid hormone generation (GO:0006590) | 34.0460773 |
| 78 | fatty acid homeostasis (GO:0055089) | 3.99735567 |
| 79 | positive regulation of insulin receptor signaling pathway (GO:0046628) | 3.99356130 |
| 80 | pentose-phosphate shunt (GO:0006098) | 3.96817382 |
| 81 | coenzyme A biosynthetic process (GO:0015937) | 3.95820939 |
| 82 | regulation of cAMP-dependent protein kinase activity (GO:2000479) | 3.94823229 |
| 83 | branched-chain amino acid catabolic process (GO:0009083) | 3.93395581 |
| 84 | negative regulation of tumor necrosis factor-mediated signaling pathway (GO:0010804) | 3.91664763 |
| 85 | regulation of steroid hormone biosynthetic process (GO:0090030) | 3.91513208 |
| 86 | carnitine transmembrane transport (GO:1902603) | 3.90254013 |
| 87 | negative regulation of phagocytosis (GO:0050765) | 3.89968717 |
| 88 | CDP-diacylglycerol biosynthetic process (GO:0016024) | 3.89297124 |
| 89 | regulation of fatty acid beta-oxidation (GO:0031998) | 3.88740846 |
| 90 | NADPH regeneration (GO:0006740) | 3.87360128 |
| 91 | positive regulation of fatty acid metabolic process (GO:0045923) | 3.84506746 |
| 92 | growth hormone receptor signaling pathway (GO:0060396) | 3.83253848 |
| 93 | fatty acid oxidation (GO:0019395) | 3.76897505 |
| 94 | glycerol metabolic process (GO:0006071) | 3.75081458 |
| 95 | female gonad development (GO:0008585) | 3.74259009 |
| 96 | regulation of fatty acid oxidation (GO:0046320) | 3.73124960 |
| 97 | lipid oxidation (GO:0034440) | 3.70163527 |
| 98 | regulation of cellular response to vascular endothelial growth factor stimulus (GO:1902547) | 3.69438070 |
| 99 | positive regulation of glucose transport (GO:0010828) | 3.67055621 |
| 100 | L-serine transport (GO:0015825) | 3.65556339 |
| 101 | plasma lipoprotein particle clearance (GO:0034381) | 3.64972591 |
| 102 | fatty acid catabolic process (GO:0009062) | 3.64609361 |
| 103 | negative regulation of lipid storage (GO:0010888) | 3.63005447 |
| 104 | positive regulation of branching involved in ureteric bud morphogenesis (GO:0090190) | 3.62851368 |
| 105 | negative regulation of granulocyte differentiation (GO:0030853) | 3.62173902 |
| 106 | cellular response to lithium ion (GO:0071285) | 3.60550777 |
| 107 | acetyl-CoA metabolic process (GO:0006084) | 3.58477286 |
| 108 | regulation of glycogen (starch) synthase activity (GO:2000465) | 3.56327368 |
| 109 | amino-acid betaine transport (GO:0015838) | 3.56245074 |
| 110 | carnitine transport (GO:0015879) | 3.56245074 |
| 111 | cellular response to epinephrine stimulus (GO:0071872) | 3.53984222 |
| 112 | diacylglycerol metabolic process (GO:0046339) | 3.53106923 |
| 113 | positive regulation of glomerulus development (GO:0090193) | 3.51382269 |
| 114 | positive regulation of lipid catabolic process (GO:0050996) | 3.49518007 |
| 115 | retina vasculature morphogenesis in camera-type eye (GO:0061299) | 3.49328147 |
| 116 | CDP-diacylglycerol metabolic process (GO:0046341) | 3.46745525 |
| 117 | membrane repolarization during cardiac muscle cell action potential (GO:0086013) | 3.44485508 |
| 118 | negative regulation of metanephros development (GO:0072217) | 3.43481384 |
| 119 | complement activation, alternative pathway (GO:0006957) | 3.42034698 |
| 120 | adaptation of signaling pathway (GO:0023058) | 3.33611662 |
| 121 | positive regulation of cholesterol efflux (GO:0010875) | 3.33254282 |
| 122 | cellular response to growth hormone stimulus (GO:0071378) | 3.32791618 |
| 123 | alpha-linolenic acid metabolic process (GO:0036109) | 3.32002174 |
| 124 | phosphatidic acid biosynthetic process (GO:0006654) | 3.31178978 |
| 125 | phosphatidic acid metabolic process (GO:0046473) | 3.31178978 |
| 126 | positive regulation of sterol transport (GO:0032373) | 3.29360476 |
| 127 | positive regulation of cholesterol transport (GO:0032376) | 3.29360476 |
| 128 | negative regulation of macrophage differentiation (GO:0045650) | 3.27939944 |
| 129 | alditol metabolic process (GO:0019400) | 3.26673675 |
| 130 | regulation of vascular endothelial growth factor signaling pathway (GO:1900746) | 3.25138082 |
| 131 | coenzyme A metabolic process (GO:0015936) | 3.21597072 |
| 132 | hair follicle morphogenesis (GO:0031069) | 3.19617267 |
| 133 | glomerular filtration (GO:0003094) | 3.19424937 |
| 134 | intracellular lipid transport (GO:0032365) | 3.18293770 |
| 135 | negative regulation of amino acid transport (GO:0051956) | 3.17188891 |
| 136 | nephron tubule development (GO:0072080) | 3.17160681 |
| 137 | oxaloacetate metabolic process (GO:0006107) | 3.16711331 |
| 138 | phosphatidylinositol dephosphorylation (GO:0046856) | 3.16484523 |
| 139 | embryonic hemopoiesis (GO:0035162) | 3.15073595 |
| 140 | positive regulation of lipid storage (GO:0010884) | 3.14682481 |
| 141 | regulation of gonadotropin secretion (GO:0032276) | 3.13003297 |
| 142 | serine transport (GO:0032329) | 3.11614065 |
| 143 | phospholipid dephosphorylation (GO:0046839) | 3.08818447 |
| 144 | negative regulation of platelet-derived growth factor receptor signaling pathway (GO:0010642) | 3.07948166 |
| 145 | regulation of Rap GTPase activity (GO:0032317) | 3.07591023 |
| 146 | fat cell differentiation (GO:0045444) | 3.06519698 |
| 147 | hormone metabolic process (GO:0042445) | 3.05770295 |
| 148 | tricarboxylic acid metabolic process (GO:0072350) | 3.05667323 |
| 149 | response to hydroperoxide (GO:0033194) | 3.01084687 |
| 150 | thyroid hormone metabolic process (GO:0042403) | 27.5784343 |
| 151 | membrane repolarization during action potential (GO:0086011) | 2.99413776 |
| 152 | positive regulation of mesonephros development (GO:0061213) | 2.95677414 |
| 153 | regulation of metanephros development (GO:0072215) | 2.91488221 |
| 154 | renal tubule development (GO:0061326) | 2.88293238 |
| 155 | regulation of branching involved in ureteric bud morphogenesis (GO:0090189) | 2.87711308 |
| 156 | negative regulation of peptidyl-serine phosphorylation (GO:0033137) | 2.80286218 |
| 157 | epithelial cell morphogenesis (GO:0003382) | 2.72772143 |
| 158 | regulation of lipoprotein metabolic process (GO:0050746) | 2.72646884 |
| 159 | positive regulation of p38MAPK cascade (GO:1900745) | 2.70011127 |
| 160 | negative regulation of stem cell differentiation (GO:2000737) | 2.57165898 |
| 161 | carnitine metabolic process (GO:0009437) | 2.53114642 |
| 162 | positive regulation of Rap GTPase activity (GO:0032854) | 2.52006815 |
| 163 | response to epinephrine (GO:0071871) | 2.50052627 |
| 164 | nephron epithelium development (GO:0072009) | 2.46519038 |
| 165 | embryonic epithelial tube formation (GO:0001838) | 2.42539412 |
| 166 | regulation of mesonephros development (GO:0061217) | 2.40301995 |
| 167 | regulation of energy homeostasis (GO:2000505) | 2.38766362 |
| 168 | branching involved in ureteric bud morphogenesis (GO:0001658) | 2.37405678 |
| 169 | inorganic anion transport (GO:0015698) | 2.34168969 |
| 170 | regulation of hormone biosynthetic process (GO:0046885) | 2.31577833 |
| 171 | epithelial tube formation (GO:0072175) | 2.28521054 |
| 172 | positive regulation of digestive system process (GO:0060456) | 2.27995218 |
| 173 | pericardium development (GO:0060039) | 2.27419315 |
| 174 | thymus development (GO:0048538) | 2.26670896 |
| 175 | cellular modified amino acid metabolic process (GO:0006575) | 2.18702326 |
| 176 | potassium ion export (GO:0071435) | 2.17743452 |
| 177 | regulation of p38MAPK cascade (GO:1900744) | 2.17739066 |
| 178 | synapse assembly (GO:0007416) | 2.17348366 |
| 179 | regulation of water loss via skin (GO:0033561) | 2.15984801 |
| 180 | regulation of hormone levels (GO:0010817) | 2.13460998 |
| 181 | regulation of apoptotic cell clearance (GO:2000425) | 2.09578881 |
| 182 | cellular response to cAMP (GO:0071320) | 2.07536913 |
| 183 | negative regulation of fatty acid transport (GO:2000192) | 2.05769184 |
| 184 | regulation of microtubule polymerization (GO:0031113) | 2.03353304 |
| 185 | regulation of ventricular cardiac muscle cell membrane repolarization (GO:0060307) | 2.03314853 |
| 186 | cellular response to follicle-stimulating hormone stimulus (GO:0071372) | 2.00423977 |
| 187 | thyroid gland development (GO:0030878) | 14.3406139 |
| 188 | sulfate transmembrane transport (GO:1902358) | 11.5000178 |
| 189 | flavonoid metabolic process (GO:0009812) | 1.99551428 |
| 190 | phospholipid homeostasis (GO:0055091) | 1.99222212 |
| 191 | regulation of glucose import in response to insulin stimulus (GO:2001273) | 1.97253731 |
| 192 | amino-acid betaine metabolic process (GO:0006577) | 1.95535667 |
| 193 | negative regulation of insulin secretion (GO:0046676) | 1.94854479 |
| 194 | atrial cardiac muscle cell action potential (GO:0086014) | 1.94568200 |
| 195 | phenol-containing compound catabolic process (GO:0019336) | 1.92658443 |
| 196 | negative regulation of lipase activity (GO:0060192) | 1.92491041 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 5.51490146 |
| 2 | CDKN2AIP_20523734_ChIP-Seq_CORTICAL_Neurons | 4.99612494 |
| 3 | EZH2_22144423_ChIP-Seq_EOC_Human | 4.61985147 |
| 4 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 4.33511037 |
| 5 | CLOCK_20551151_ChIP-Seq_293T_Human | 4.29768511 |
| 6 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 3.64406071 |
| 7 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 3.21314174 |
| 8 | AR_21572438_ChIP-Seq_LNCaP_Human | 2.92532574 |
| 9 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 2.71489786 |
| 10 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 2.53184807 |
| 11 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 2.52721457 |
| 12 | PPARG_20176806_ChIP-Seq_3T3-L1_Mouse | 2.51758290 |
| 13 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 2.39293452 |
| 14 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 2.29706323 |
| 15 | RUNX1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 2.27472980 |
| 16 | GBX2_23144817_ChIP-Seq_PC3_Human | 2.16970673 |
| 17 | SMAD3_21741376_ChIP-Seq_HESCs_Human | 2.12621578 |
| 18 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 2.05882767 |
| 19 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 2.00205820 |
| 20 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 13.7099354 |
| 21 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.95425128 |
| 22 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 1.93486307 |
| 23 | PPARG_20887899_ChIP-Seq_3T3-L1_Mouse | 1.88185824 |
| 24 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 1.79278175 |
| 25 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 1.72222310 |
| 26 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 1.69210012 |
| 27 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 1.61850534 |
| 28 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.61242303 |
| 29 | IGF1R_20145208_ChIP-Seq_DFB_Human | 1.60578753 |
| 30 | GATA1_22025678_ChIP-Seq_K562_Human | 1.60246199 |
| 31 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.58438940 |
| 32 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 1.58377293 |
| 33 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 1.57379279 |
| 34 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 1.57004663 |
| 35 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 1.56597119 |
| 36 | RNF2_27304074_Chip-Seq_ESCs_Mouse | 1.56241783 |
| 37 | NFIB_24661679_ChIP-Seq_LUNG_Mouse | 1.54802539 |
| 38 | * SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 1.52776484 |
| 39 | TP53_16413492_ChIP-PET_HCT116_Human | 1.52767580 |
| 40 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.51558634 |
| 41 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.50824502 |
| 42 | SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 1.48203859 |
| 43 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.42038698 |
| 44 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.39152485 |
| 45 | EP300_21415370_ChIP-Seq_HL-1_Mouse | 1.37999231 |
| 46 | TEAD4_22529382_ChIP-Seq_TROPHECTODERM_Mouse | 1.37914371 |
| 47 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 1.37858106 |
| 48 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 1.35265739 |
| 49 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 1.35265739 |
| 50 | BMI1_23680149_ChIP-Seq_NPCS_Mouse | 1.34507019 |
| 51 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.33667953 |
| 52 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 1.33494249 |
| 53 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 1.30636067 |
| 54 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 1.28859343 |
| 55 | * CJUN_26792858_Chip-Seq_BT549_Human | 1.27505071 |
| 56 | SMAD4_21799915_ChIP-Seq_A2780_Human | 1.25981261 |
| 57 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 1.25582547 |
| 58 | SMAD4_21741376_ChIP-Seq_HESCs_Human | 1.24862867 |
| 59 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 1.22932458 |
| 60 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 1.22856719 |
| 61 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.22493309 |
| 62 | VDR_20736230_ChIP-Seq_LYMPHOBLASTOID_Human | 1.21700241 |
| 63 | CEBPD_21427703_ChIP-Seq_3T3-L1_Mouse | 1.21683589 |
| 64 | PHC1_16625203_ChIP-ChIP_MESCs_Mouse | 1.20355598 |
| 65 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.19641565 |
| 66 | TBX20_22328084_ChIP-Seq_HEART_Mouse | 1.17785966 |
| 67 | TBX20_22080862_ChIP-Seq_HEART_Mouse | 1.17785966 |
| 68 | RUNX_20019798_ChIP-Seq_JUKART_Human | 1.16117117 |
| 69 | SMAD4_19686287_ChIP-ChIP_HaCaT_Human | 1.15919422 |
| 70 | SCL_19346495_ChIP-Seq_HPC-7_Human | 1.15484530 |
| 71 | * SMAD3_21741376_ChIP-Seq_EPCs_Human | 1.15390131 |
| 72 | * RING1B_27294783_Chip-Seq_NPCs_Mouse | 1.14359621 |
| 73 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 1.14072909 |
| 74 | SOX9_24532713_ChIP-Seq_HFSC_Mouse | 1.13493297 |
| 75 | WDR5_24793694_ChIP-Seq_LNCAP_Human | 1.12967109 |
| 76 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 1.12653734 |
| 77 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.12305642 |
| 78 | ER_23166858_ChIP-Seq_MCF-7_Human | 1.10710166 |
| 79 | ZNF263_19887448_ChIP-Seq_K562_Human | 1.08998362 |
| 80 | YAP1_20516196_ChIP-Seq_MESCs_Mouse | 1.08756492 |
| 81 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 1.07433149 |
| 82 | AR_21915096_ChIP-Seq_LNCaP-1F5_Human | 1.07272634 |
| 83 | FOXA1_21915096_ChIP-Seq_LNCaP-1F5_Human | 1.06418808 |
| 84 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 1.06239421 |
| 85 | SOX9_26525672_Chip-Seq_Limbbuds_Mouse | 1.06220650 |
| 86 | RUNX2_22187159_ChIP-Seq_PCA_Human | 1.05870892 |
| 87 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 1.05442039 |
| 88 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.04595042 |
| 89 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 1.03195548 |
| 90 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.02651560 |
| 91 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 1.02479362 |
| 92 | TBX3_20139965_ChIP-Seq_MESCs_Mouse | 1.01736018 |
| 93 | * SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 1.01055031 |
| 94 | TP53_18474530_ChIP-ChIP_U2OS_Human | 1.00973109 |
| 95 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 1.00351176 |
| 96 | TBX3_20139965_ChIP-Seq_ESCs_Mouse | 1.00149138 |
| 97 | BCAT_22108803_ChIP-Seq_LS180_Human | 0.99565984 |
| 98 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 0.98703190 |
| 99 | FOXM1_26456572_ChIP-Seq_MCF-7_Human | 0.98346604 |
| 100 | TCF4_18268006_ChIP-ChIP_LS174T_Human | 0.98241062 |
| 101 | SOX2_20726797_ChIP-Seq_SW620_Human | 0.98189514 |
| 102 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 0.96979254 |
| 103 | * SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 0.96782936 |
| 104 | NR3C1_21868756_ChIP-Seq_MCF10A_Human | 0.95773131 |
| 105 | RNF2_16625203_ChIP-ChIP_MESCs_Mouse | 0.95187718 |
| 106 | RXR_22108803_ChIP-Seq_LS180_Human | 0.93839544 |
| 107 | * MEIS1_26253404_ChIP-Seq_OPTIC_CUPS_Mouse | 0.93651054 |
| 108 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.93154873 |
| 109 | ELK4_26923725_Chip-Seq_MESODERM_Mouse | 0.93019389 |
| 110 | AR_19668381_ChIP-Seq_PC3_Human | 0.92243760 |
| 111 | * STAT3_23295773_ChIP-Seq_U87_Human | 0.91884170 |
| 112 | * CTNNB1_20460455_ChIP-Seq_HCT116_Human | 0.91707300 |
| 113 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 0.91228792 |
| 114 | P300_27058665_Chip-Seq_ZR-75-30cells_Human | 0.88955601 |
| 115 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 0.88614891 |
| 116 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 0.86769018 |
| 117 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 0.86769018 |
| 118 | RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 0.86557158 |
| 119 | * MTF2_20144788_ChIP-Seq_MESCs_Mouse | 0.86518067 |
| 120 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 0.84946846 |
| 121 | NR3C1_23031785_ChIP-Seq_PC12_Mouse | 0.84721391 |
| 122 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 0.84528278 |
| 123 | WT1_25993318_ChIP-Seq_PODOCYTE_Human | 0.84525316 |
| 124 | TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 0.82784853 |
| 125 | DROSHA_22980978_ChIP-Seq_HELA_Human | 0.82374330 |
| 126 | P63_26484246_Chip-Seq_KERATINOCYTES_Human | 0.81000074 |
| 127 | WT1_20215353_ChIP-ChIP_NEPHRON_PROGENITOR_Mouse | 0.80984665 |
| 128 | HIF1A_21447827_ChIP-Seq_MCF-7_Human | 0.79275523 |
| 129 | EP300_20729851_ChIP-Seq_FORBRAIN_MIDBRAIN_LIMB_HEART_Mouse | 0.78241522 |
| 130 | GATA1_19941826_ChIP-Seq_K562_Human | 0.77224900 |
| 131 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 0.76655512 |
| 132 | ERA_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.76353329 |
| 133 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 0.75078270 |
| 134 | GATA3_24758297_ChIP-Seq_MCF-7_Human | 0.74769569 |
| 135 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 0.74758818 |
| 136 | * MYB_21317192_ChIP-Seq_ERMYB_Mouse | 0.74679259 |
| 137 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 0.74659656 |
| 138 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 0.74549213 |
| 139 | EWS-FLI1_20517297_ChIP-Seq_SK-N-MC_Human | 0.73734047 |
| 140 | FOXA2_19822575_ChIP-Seq_HepG2_Human | 0.73232439 |
| 141 | SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.72624829 |
| 142 | KLF4_19829295_ChIP-Seq_ESCs_Human | 0.72477207 |
| 143 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.70446586 |
| 144 | PPARD_23208498_ChIP-Seq_MDA-MB-231_Human | 0.69773095 |
| 145 | * SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 0.67572370 |
| 146 | KDM2B_26808549_Chip-Seq_K562_Human | 0.67370615 |
| 147 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 0.67057376 |
| 148 | AHR_22903824_ChIP-Seq_MCF-7_Human | 0.66353246 |
| 149 | ELF3_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.65224281 |
| 150 | GATA2_19941826_ChIP-Seq_K562_Human | 0.64644876 |
| 151 | JUND_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.64504698 |
| 152 | SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 0.64304215 |
| 153 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 0.63890966 |
| 154 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.63347240 |
| 155 | ISL1_27105846_Chip-Seq_CPCs_Mouse | 0.63035278 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0005670_abnormal_white_adipose | 8.32702852 |
| 2 | MP0000383_abnormal_hair_follicle | 5.61481737 |
| 3 | MP0004043_abnormal_pH_regulation | 5.42103221 |
| 4 | MP0004885_abnormal_endolymph | 5.36734976 |
| 5 | MP0005666_abnormal_adipose_tissue | 5.32161070 |
| 6 | MP0008438_abnormal_cutaneous_collagen | 5.01949174 |
| 7 | MP0004130_abnormal_muscle_cell | 4.58862369 |
| 8 | MP0010678_abnormal_skin_adnexa | 4.56866915 |
| 9 | MP0004185_abnormal_adipocyte_glucose | 4.51851039 |
| 10 | MP0005375_adipose_tissue_phenotype | 4.14909361 |
| 11 | MP0003879_abnormal_hair_cell | 4.01208557 |
| 12 | MP0001485_abnormal_pinna_reflex | 3.68434202 |
| 13 | MP0000013_abnormal_adipose_tissue | 3.50822076 |
| 14 | MP0010368_abnormal_lymphatic_system | 3.36633300 |
| 15 | MP0002837_dystrophic_cardiac_calcinosis | 3.36291120 |
| 16 | MP0005275_abnormal_skin_tensile | 3.07959468 |
| 17 | MP0004742_abnormal_vestibular_system | 3.06757815 |
| 18 | MP0000003_abnormal_adipose_tissue | 3.06348864 |
| 19 | MP0002971_abnormal_brown_adipose | 2.99092281 |
| 20 | MP0009115_abnormal_fat_cell | 2.81226776 |
| 21 | MP0003890_abnormal_embryonic-extraembry | 2.51187132 |
| 22 | MP0010329_abnormal_lipoprotein_level | 2.50901520 |
| 23 | MP0005334_abnormal_fat_pad | 2.48765619 |
| 24 | * MP0002876_abnormal_thyroid_physiology | 2.41987998 |
| 25 | MP0003191_abnormal_cellular_cholesterol | 2.36325498 |
| 26 | MP0001661_extended_life_span | 2.35621838 |
| 27 | MP0002970_abnormal_white_adipose | 2.13485630 |
| 28 | MP0004272_abnormal_basement_membrane | 2.10131404 |
| 29 | MP0003868_abnormal_feces_composition | 1.98614262 |
| 30 | MP0003959_abnormal_lean_body | 1.91358496 |
| 31 | MP0002254_reproductive_system_inflammat | 1.78795302 |
| 32 | MP0005535_abnormal_body_temperature | 1.78158867 |
| 33 | * MP0002118_abnormal_lipid_homeostasis | 1.70862574 |
| 34 | MP0001881_abnormal_mammary_gland | 1.66858699 |
| 35 | MP0003690_abnormal_glial_cell | 1.66128112 |
| 36 | MP0003705_abnormal_hypodermis_morpholog | 1.62524797 |
| 37 | MP0002638_abnormal_pupillary_reflex | 1.58335333 |
| 38 | MP0003938_abnormal_ear_development | 1.51863527 |
| 39 | MP0003186_abnormal_redox_activity | 1.44926242 |
| 40 | MP0005448_abnormal_energy_balance | 1.43469111 |
| 41 | MP0009780_abnormal_chondrocyte_physiolo | 1.39965917 |
| 42 | MP0001727_abnormal_embryo_implantation | 1.35214730 |
| 43 | MP0003724_increased_susceptibility_to | 1.31702950 |
| 44 | MP0003136_yellow_coat_color | 1.30012966 |
| 45 | MP0005452_abnormal_adipose_tissue | 1.29888315 |
| 46 | MP0003566_abnormal_cell_adhesion | 1.27712960 |
| 47 | MP0002822_catalepsy | 1.24564874 |
| 48 | MP0003011_delayed_dark_adaptation | 1.22845997 |
| 49 | MP0000631_abnormal_neuroendocrine_gland | 1.22779532 |
| 50 | MP0004264_abnormal_extraembryonic_tissu | 1.22291786 |
| 51 | * MP0000026_abnormal_inner_ear | 1.16634043 |
| 52 | * MP0001963_abnormal_hearing_physiology | 1.16342310 |
| 53 | MP0003183_abnormal_peptide_metabolism | 1.13170512 |
| 54 | MP0000920_abnormal_myelination | 1.12489289 |
| 55 | MP0001765_abnormal_ion_homeostasis | 1.12091589 |
| 56 | MP0003045_fibrosis | 1.11289608 |
| 57 | MP0002796_impaired_skin_barrier | 1.11162284 |
| 58 | MP0000751_myopathy | 1.08907363 |
| 59 | MP0002078_abnormal_glucose_homeostasis | 1.08321249 |
| 60 | MP0002166_altered_tumor_susceptibility | 1.07816895 |
| 61 | MP0000609_abnormal_liver_physiology | 1.07434271 |
| 62 | MP0006138_congestive_heart_failure | 1.05696045 |
| 63 | MP0002060_abnormal_skin_morphology | 1.04305106 |
| 64 | MP0001177_atelectasis | 1.03704886 |
| 65 | MP0004381_abnormal_hair_follicle | 1.03001958 |
| 66 | MP0002909_abnormal_adrenal_gland | 1.01850712 |
| 67 | MP0000343_altered_response_to | 1.00051885 |
| 68 | MP0005645_abnormal_hypothalamus_physiol | 0.99248322 |
| 69 | MP0003828_pulmonary_edema | 0.97988997 |
| 70 | MP0001756_abnormal_urination | 0.96532159 |
| 71 | MP0005164_abnormal_response_to | 0.96387736 |
| 72 | MP0000750_abnormal_muscle_regeneration | 0.96362420 |
| 73 | MP0005379_endocrine/exocrine_gland_phen | 0.90828060 |
| 74 | MP0008995_early_reproductive_senescence | 0.90044099 |
| 75 | MP0002653_abnormal_ependyma_morphology | 0.88850349 |
| 76 | MP0008775_abnormal_heart_ventricle | 0.87443702 |
| 77 | MP0005620_abnormal_muscle_contractility | 0.87254507 |
| 78 | MP0004484_altered_response_of | 0.86656382 |
| 79 | MP0002229_neurodegeneration | 0.83394792 |
| 80 | MP0001502_abnormal_circadian_rhythm | 0.82389561 |
| 81 | MP0004134_abnormal_chest_morphology | 0.81863078 |
| 82 | * MP0008569_lethality_at_weaning | 0.81829480 |
| 83 | MP0003948_abnormal_gas_homeostasis | 0.80998560 |
| 84 | MP0001764_abnormal_homeostasis | 0.79876511 |
| 85 | MP0002006_tumorigenesis | 0.79839041 |
| 86 | MP0008875_abnormal_xenobiotic_pharmacok | 0.79188481 |
| 87 | MP0001984_abnormal_olfaction | 0.76677768 |
| 88 | MP0005365_abnormal_bile_salt | 0.76137308 |
| 89 | * MP0000681_abnormal_thyroid_gland | 0.74880568 |
| 90 | MP0001958_emphysema | 0.73968085 |
| 91 | MP0005584_abnormal_enzyme/coenzyme_acti | 0.72897578 |
| 92 | MP0003950_abnormal_plasma_membrane | 0.72780316 |
| 93 | MP0001544_abnormal_cardiovascular_syste | 0.72448924 |
| 94 | MP0005385_cardiovascular_system_phenoty | 0.72448924 |
| 95 | MP0005076_abnormal_cell_differentiation | 0.72136478 |
| 96 | * MP0003953_abnormal_hormone_level | 0.71848533 |
| 97 | MP0009643_abnormal_urine_homeostasis | 0.70695873 |
| 98 | MP0005409_darkened_coat_color | 0.70431850 |
| 99 | MP0003935_abnormal_craniofacial_develop | 0.69960458 |
| 100 | MP0000759_abnormal_skeletal_muscle | 0.68750762 |
| 101 | MP0010771_integument_phenotype | 0.68466293 |
| 102 | MP0002168_other_aberrant_phenotype | 0.67432618 |
| 103 | MP0000049_abnormal_middle_ear | 0.65457788 |
| 104 | MP0002133_abnormal_respiratory_system | 0.65290658 |
| 105 | MP0005388_respiratory_system_phenotype | 0.65290658 |
| 106 | MP0005647_abnormal_sex_gland | 0.64920141 |
| 107 | MP0000377_abnormal_hair_follicle | 0.64796848 |
| 108 | MP0010234_abnormal_vibrissa_follicle | 0.64744405 |
| 109 | MP0002295_abnormal_pulmonary_circulatio | 0.64109054 |
| 110 | MP0004087_abnormal_muscle_fiber | 0.63944866 |
| 111 | MP0002877_abnormal_melanocyte_morpholog | 0.63148023 |
| 112 | MP0005058_abnormal_lysosome_morphology | 0.63067621 |
| 113 | MP0004215_abnormal_myocardial_fiber | 0.62302405 |
| 114 | MP0001533_abnormal_skeleton_physiology | 0.62283187 |
| 115 | MP0005023_abnormal_wound_healing | 0.62189762 |
| 116 | MP0005167_abnormal_blood-brain_barrier | 0.61355338 |
| 117 | MP0003936_abnormal_reproductive_system | 0.60255128 |
| 118 | MP0002108_abnormal_muscle_morphology | 0.59585690 |
| 119 | MP0004147_increased_porphyrin_level | 0.59401255 |
| 120 | MP0000604_amyloidosis | 0.58911872 |
| 121 | MP0002177_abnormal_outer_ear | 0.58488199 |
| 122 | MP0005377_hearing/vestibular/ear_phenot | 0.58040307 |
| 123 | MP0003878_abnormal_ear_physiology | 0.58040307 |
| 124 | * MP0001501_abnormal_sleep_pattern | 0.57980607 |
| 125 | MP0000249_abnormal_blood_vessel | 0.57525017 |
| 126 | MP0002998_abnormal_bone_remodeling | 0.54779263 |
| 127 | MP0003329_amyloid_beta_deposits | 0.54471330 |
| 128 | MP0000230_abnormal_systemic_arterial | 0.54389049 |
| 129 | MP0008961_abnormal_basal_metabolism | 0.53595508 |
| 130 | MP0001879_abnormal_lymphatic_vessel | 0.53125955 |
| 131 | MP0010386_abnormal_urinary_bladder | 0.52917313 |
| 132 | MP0000858_altered_metastatic_potential | 0.52026887 |
| 133 | MP0005319_abnormal_enzyme/_coenzyme | 0.50746819 |
| 134 | MP0005310_abnormal_salivary_gland | 0.50696062 |
| 135 | MP0006054_spinal_hemorrhage | 0.50164448 |
| 136 | MP0003448_altered_tumor_morphology | 0.50114663 |
| 137 | MP0000627_abnormal_mammary_gland | 0.49721892 |
| 138 | MP0005595_abnormal_vascular_smooth | 0.49283652 |
| 139 | MP0002972_abnormal_cardiac_muscle | 0.47754455 |
| 140 | MP0000367_abnormal_coat/_hair | 0.47116894 |
| 141 | MP0005171_absent_coat_pigmentation | 0.46852713 |
| 142 | MP0002332_abnormal_exercise_endurance | 0.45415631 |
| 143 | MP0010352_gastrointestinal_tract_polyps | 0.43867303 |
| 144 | MP0008004_abnormal_stomach_pH | 0.43450706 |
| 145 | MP0000427_abnormal_hair_cycle | 0.43342982 |
| 146 | MP0005165_increased_susceptibility_to | 0.43342711 |
| 147 | MP0002090_abnormal_vision | 0.43024792 |
| 148 | MP0006036_abnormal_mitochondrial_physio | 0.42198278 |
| 149 | MP0001851_eye_inflammation | 0.40307749 |
| 150 | MP0000465_gastrointestinal_hemorrhage | 0.39553232 |
| 151 | MP0003646_muscle_fatigue | 0.38099811 |
| 152 | MP0004084_abnormal_cardiac_muscle | 0.37372772 |
| 153 | MP0009278_abnormal_bone_marrow | 0.36711694 |
| 154 | MP0003755_abnormal_palate_morphology | 0.35684190 |
| 155 | MP0003638_abnormal_response/metabolism_ | 0.35057851 |
| 156 | MP0003137_abnormal_impulse_conducting | 0.33079557 |
| 157 | * MP0009642_abnormal_blood_homeostasis | 0.31804227 |
| 158 | MP0001663_abnormal_digestive_system | 0.31075178 |
| 159 | MP0005075_abnormal_melanosome_morpholog | 0.30950648 |
| 160 | MP0005395_other_phenotype | 0.30790013 |
| 161 | MP0003300_gastrointestinal_ulcer | 0.30711455 |
| 162 | MP0009703_decreased_birth_body | 0.30205573 |
| 163 | MP0002136_abnormal_kidney_physiology | 0.29957060 |
| 164 | MP0003453_abnormal_keratinocyte_physiol | 0.29460956 |
| 165 | MP0003937_abnormal_limbs/digits/tail_de | 0.28330726 |
| 166 | MP0003942_abnormal_urinary_system | 0.27658494 |
| 167 | * MP0001731_abnormal_postnatal_growth | 0.26619290 |
| 168 | MP0001145_abnormal_male_reproductive | 0.26023814 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Congenital sensorineural hearing impairment (HP:0008527) | 9.92453766 |
| 2 | Oligomenorrhea (HP:0000876) | 9.10862134 |
| 3 | Small epiphyses (HP:0010585) | 8.64809150 |
| 4 | Thyroid carcinoma (HP:0002890) | 8.40874907 |
| 5 | Abnormality of cochlea (HP:0000375) | 8.06171821 |
| 6 | Acanthosis nigricans (HP:0000956) | 7.63621274 |
| 7 | Hypothermia (HP:0002045) | 7.28131358 |
| 8 | Abnormal hair laboratory examination (HP:0003328) | 6.43189935 |
| 9 | Hypertriglyceridemia (HP:0002155) | 6.35143511 |
| 10 | Morphological abnormality of the inner ear (HP:0011390) | 6.34098295 |
| 11 | * Hypothyroidism (HP:0000821) | 5.68623689 |
| 12 | Delayed epiphyseal ossification (HP:0002663) | 5.55166550 |
| 13 | Hyperglycinuria (HP:0003108) | 5.27474882 |
| 14 | Irregular epiphyses (HP:0010582) | 4.91736914 |
| 15 | Mild short stature (HP:0003502) | 4.73680504 |
| 16 | Long foot (HP:0001833) | 4.52876067 |
| 17 | Insulin-resistant diabetes mellitus (HP:0000831) | 4.51709199 |
| 18 | Complement deficiency (HP:0004431) | 4.47495457 |
| 19 | * Coarse facial features (HP:0000280) | 4.31282306 |
| 20 | Difficulty running (HP:0009046) | 4.17784748 |
| 21 | Epiphyseal dysplasia (HP:0002656) | 4.16089307 |
| 22 | Aortic dissection (HP:0002647) | 4.07469114 |
| 23 | Abnormality of serine family amino acid metabolism (HP:0010894) | 4.07066017 |
| 24 | Abnormality of glycine metabolism (HP:0010895) | 4.07066017 |
| 25 | Neoplasm of the thyroid gland (HP:0100031) | 3.90812266 |
| 26 | Hyperparathyroidism (HP:0000843) | 3.83432257 |
| 27 | Increased connective tissue (HP:0009025) | 3.76283011 |
| 28 | Pigmentary retinal degeneration (HP:0001146) | 3.65292626 |
| 29 | Growth hormone excess (HP:0000845) | 3.64973116 |
| 30 | Ankle contracture (HP:0006466) | 3.51045531 |
| 31 | Hemorrhage of the eye (HP:0011885) | 3.46377647 |
| 32 | Insulin resistance (HP:0000855) | 3.46025714 |
| 33 | * Constipation (HP:0002019) | 3.42455354 |
| 34 | Bone cyst (HP:0012062) | 3.34630865 |
| 35 | Abnormality of proline metabolism (HP:0010907) | 3.32776388 |
| 36 | Hydroxyprolinuria (HP:0003080) | 3.32776388 |
| 37 | Cerebral aneurysm (HP:0004944) | 3.29748058 |
| 38 | Subcapsular cataract (HP:0000523) | 3.28192642 |
| 39 | Arterial tortuosity (HP:0005116) | 3.27533933 |
| 40 | Tracheal stenosis (HP:0002777) | 3.21095370 |
| 41 | Increased variability in muscle fiber diameter (HP:0003557) | 3.17238123 |
| 42 | Broad metatarsal (HP:0001783) | 3.15402958 |
| 43 | Abnormality of complement system (HP:0005339) | 3.10933492 |
| 44 | Macroglossia (HP:0000158) | 3.10904092 |
| 45 | Bradycardia (HP:0001662) | 3.04893839 |
| 46 | Autoimmune thrombocytopenia (HP:0001973) | 3.02767613 |
| 47 | Type 1 muscle fiber predominance (HP:0003803) | 2.99019158 |
| 48 | Vascular tortuosity (HP:0004948) | 2.96761739 |
| 49 | Large hands (HP:0001176) | 2.95717891 |
| 50 | Reduced subcutaneous adipose tissue (HP:0003758) | 2.95560194 |
| 51 | Slender build (HP:0001533) | 2.95163913 |
| 52 | Aortic aneurysm (HP:0004942) | 2.93214523 |
| 53 | Systemic lupus erythematosus (HP:0002725) | 2.87415165 |
| 54 | Myoglobinuria (HP:0002913) | 2.86141763 |
| 55 | Premature rupture of membranes (HP:0001788) | 2.84860592 |
| 56 | Hoarse voice (HP:0001609) | 2.84269133 |
| 57 | Follicular hyperkeratosis (HP:0007502) | 2.81377439 |
| 58 | Spondylolisthesis (HP:0003302) | 2.79004919 |
| 59 | Tetraparesis (HP:0002273) | 2.76196662 |
| 60 | Muscle fiber splitting (HP:0003555) | 2.74114552 |
| 61 | Spinal rigidity (HP:0003306) | 2.70633724 |
| 62 | Ketoacidosis (HP:0001993) | 2.67013579 |
| 63 | Facial diplegia (HP:0001349) | 2.66317662 |
| 64 | Abnormality of skeletal muscle fiber size (HP:0012084) | 2.63540161 |
| 65 | Abnormal eating behavior (HP:0100738) | 2.59001144 |
| 66 | Multiple enchondromatosis (HP:0005701) | 2.58265789 |
| 67 | Rectal prolapse (HP:0002035) | 2.57232768 |
| 68 | Hypoalphalipoproteinemia (HP:0003233) | 2.53467100 |
| 69 | Testicular atrophy (HP:0000029) | 2.53445359 |
| 70 | Myocardial infarction (HP:0001658) | 2.51929951 |
| 71 | Abnormality of fatty-acid metabolism (HP:0004359) | 2.47344360 |
| 72 | Hyporeflexia of lower limbs (HP:0002600) | 2.47129664 |
| 73 | Right ventricular cardiomyopathy (HP:0011663) | 2.46856963 |
| 74 | Ketosis (HP:0001946) | 2.46549188 |
| 75 | Epidermoid cyst (HP:0200040) | 2.44449643 |
| 76 | Pancreatitis (HP:0001733) | 2.43404511 |
| 77 | Lower limb hyperreflexia (HP:0002395) | 2.42818950 |
| 78 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 2.41894483 |
| 79 | * Umbilical hernia (HP:0001537) | 2.38758688 |
| 80 | Prominent supraorbital ridges (HP:0000336) | 2.38482970 |
| 81 | Mitral valve prolapse (HP:0001634) | 2.37221308 |
| 82 | Abnormal hemoglobin (HP:0011902) | 2.32517258 |
| 83 | Lipoatrophy (HP:0100578) | 2.31502527 |
| 84 | Ventricular fibrillation (HP:0001663) | 2.29510637 |
| 85 | Polyphagia (HP:0002591) | 2.28334699 |
| 86 | Increased muscle lipid content (HP:0009058) | 2.27943222 |
| 87 | Proximal amyotrophy (HP:0007126) | 2.19540563 |
| 88 | Bronchomalacia (HP:0002780) | 2.17316222 |
| 89 | Hypoglycemic coma (HP:0001325) | 2.16020669 |
| 90 | * Hyperpituitarism (HP:0010514) | 2.14725861 |
| 91 | Rhabdomyolysis (HP:0003201) | 2.14212176 |
| 92 | Abnormal cartilage morphology (HP:0002763) | 2.12823899 |
| 93 | Neonatal hypoglycemia (HP:0001998) | 2.10603463 |
| 94 | Shallow orbits (HP:0000586) | 2.10431537 |
| 95 | * Hyperthyroidism (HP:0000836) | 2.09475638 |
| 96 | Polar cataract (HP:0010696) | 2.09439532 |
| 97 | Venous abnormality (HP:0002624) | 2.05636159 |
| 98 | Scapular winging (HP:0003691) | 2.05477943 |
| 99 | Abnormality of the dental pulp (HP:0006479) | 2.04460727 |
| 100 | Glucose intolerance (HP:0000833) | 2.04130222 |
| 101 | Delayed closure of the anterior fontanelle (HP:0001476) | 2.01074492 |
| 102 | Polygenic inheritance (HP:0010982) | 2.00070711 |
| 103 | * Goiter (HP:0000853) | 17.3020305 |
| 104 | * Thyroid-stimulating hormone excess (HP:0002925) | 11.5071319 |
| 105 | Pili torti (HP:0003777) | 10.5066536 |
| 106 | * Aplasia/Hypoplasia of the abdominal wall musculature (HP:0010318) | 10.2949883 |
| 107 | Fibular hypoplasia (HP:0003038) | 1.98868249 |
| 108 | Toxemia of pregnancy (HP:0100603) | 1.98135707 |
| 109 | Hypercortisolism (HP:0001578) | 1.97756602 |
| 110 | Skin nodule (HP:0200036) | 1.95228724 |
| 111 | Decreased subcutaneous fat (HP:0001002) | 1.94161229 |
| 112 | Nausea (HP:0002018) | 1.92759892 |
| 113 | Hyperglycinemia (HP:0002154) | 1.90675225 |
| 114 | Hyperammonemia (HP:0001987) | 1.89831735 |
| 115 | Amelogenesis imperfecta (HP:0000705) | 1.89329456 |
| 116 | Abnormality of permanent molar morphology (HP:0011071) | 1.89175790 |
| 117 | Abnormality of the dental root (HP:0006486) | 1.89175790 |
| 118 | Taurodontia (HP:0000679) | 1.89175790 |
| 119 | Striae distensae (HP:0001065) | 1.88467879 |
| 120 | Soft skin (HP:0000977) | 1.87762919 |
| 121 | Turricephaly (HP:0000262) | 1.87628677 |
| 122 | Amyloidosis (HP:0011034) | 1.84232606 |
| 123 | Genu varum (HP:0002970) | 1.82875956 |
| 124 | Abnormality of the vitreous humor (HP:0004327) | 1.82757734 |
| 125 | Hyperactive renin-angiotensin system (HP:0000841) | 1.82724540 |
| 126 | Laryngomalacia (HP:0001601) | 1.82696238 |
| 127 | Protrusio acetabuli (HP:0003179) | 1.82140144 |
| 128 | Osteolytic defects of the hand bones (HP:0009699) | 1.81475975 |
| 129 | Osteolytic defects of the phalanges of the hand (HP:0009771) | 1.81475975 |
| 130 | Myotonia (HP:0002486) | 1.79867330 |
| 131 | Enlarged penis (HP:0000040) | 1.79402059 |
| 132 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 1.79303655 |
| 133 | Dicarboxylic aciduria (HP:0003215) | 1.79303655 |
| 134 | Hypoplasia of the iris (HP:0007676) | 1.79051675 |
| 135 | Gonadotropin excess (HP:0000837) | 1.78559100 |
| 136 | Abdominal distention (HP:0003270) | 1.77438795 |
| 137 | Abnormality of the lumbar spine (HP:0100712) | 1.77258092 |
| 138 | Aneurysm (HP:0002617) | 1.76575851 |
| 139 | Dilatation of the ascending aorta (HP:0005111) | 1.76317378 |
| 140 | Truncal obesity (HP:0001956) | 1.75546019 |
| 141 | Abnormality of molar morphology (HP:0011070) | 1.73927470 |
| 142 | Abnormality of molar (HP:0011077) | 1.73927470 |
| 143 | Large for gestational age (HP:0001520) | 1.67898766 |
| 144 | Neonatal respiratory distress (HP:0002643) | 1.59682331 |
| 145 | Dysdiadochokinesis (HP:0002075) | 1.57626040 |
| 146 | Hypokinesia (HP:0002375) | 1.48749180 |
| 147 | Adrenal overactivity (HP:0002717) | 1.48321045 |
| 148 | Split foot (HP:0001839) | 1.44533572 |
| 149 | Abnormality of secondary sexual hair (HP:0009888) | 1.44108924 |
| 150 | Abnormality of the axillary hair (HP:0100134) | 1.44108924 |
| 151 | Subacute progressive viral hepatitis (HP:0006572) | 1.43899573 |
| 152 | Macroorchidism (HP:0000053) | 1.42864134 |
| 153 | Vertigo (HP:0002321) | 1.40404795 |
| 154 | Abnormal epiphyseal ossification (HP:0010656) | 1.38264682 |
| 155 | Hyperbilirubinemia (HP:0002904) | 1.36942537 |
| 156 | Germ cell neoplasia (HP:0100728) | 1.33548987 |
| 157 | Dysmetric saccades (HP:0000641) | 1.30859330 |
| 158 | Glomerulonephritis (HP:0000099) | 1.29751964 |
| 159 | Choanal atresia (HP:0000453) | 1.29027550 |
| 160 | Seborrheic dermatitis (HP:0001051) | 1.26914732 |
| 161 | Hyperaldosteronism (HP:0000859) | 1.26896850 |
| 162 | Ulnar bowing (HP:0003031) | 1.25747839 |
| 163 | Hyperkalemia (HP:0002153) | 1.25109282 |
| 164 | Labial hypoplasia (HP:0000066) | 1.25104175 |
| 165 | Vaginal fistula (HP:0004320) | 1.21525585 |
| 166 | Syncope (HP:0001279) | 1.21413167 |
| 167 | Osteoarthritis (HP:0002758) | 1.18753480 |
| 168 | Hypoplastic female external genitalia (HP:0012815) | 1.17781331 |
| 169 | Prolonged QT interval (HP:0001657) | 1.17027927 |
| 170 | Synostosis involving the elbow (HP:0003938) | 1.12473574 |
| 171 | Humeroradial synostosis (HP:0003041) | 1.12473574 |
| 172 | Interstitial pulmonary disease (HP:0006530) | 1.12140663 |
| 173 | Purpura (HP:0000979) | 1.11597164 |
| 174 | Abnormality of chloride homeostasis (HP:0011422) | 1.06391781 |
| 175 | Autoimmune hemolytic anemia (HP:0001890) | 1.02232127 |
| 176 | Dry skin (HP:0000958) | 1.01745663 |
| 177 | Lethargy (HP:0001254) | 1.01482642 |
| 178 | Atelectasis (HP:0100750) | 0.99710172 |
| 179 | Broad face (HP:0000283) | 0.97334436 |
| 180 | Nephropathy (HP:0000112) | 0.97028337 |
| 181 | Viral hepatitis (HP:0006562) | 0.96773988 |
| 182 | Vascular calcification (HP:0004934) | 0.95798830 |
| 183 | Anal stenosis (HP:0002025) | 0.90921092 |
| 184 | Cardiovascular calcification (HP:0011915) | 0.90509474 |
| 185 | Abnormality of the gastric mucosa (HP:0004295) | 0.89295656 |
| 186 | Acne (HP:0001061) | 0.88920128 |
| 187 | Overgrowth (HP:0001548) | 0.88279204 |
| 188 | Abnormality of renin-angiotensin system (HP:0000847) | 0.87710092 |
| 189 | Truncus arteriosus (HP:0001660) | 0.87396034 |
| 190 | Craniofacial hyperostosis (HP:0004493) | 0.86607826 |
| 191 | Mitral stenosis (HP:0001718) | 0.86183328 |
| 192 | Decreased circulating renin level (HP:0003351) | 0.86137011 |
| 193 | Bowel incontinence (HP:0002607) | 0.85862036 |
| 194 | Hypertensive crisis (HP:0100735) | 0.85795910 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | AKT3 | 7.08942501 |
| 2 | CAMK1D | 6.91422130 |
| 3 | CAMK1G | 5.20979268 |
| 4 | TRIB3 | 4.83361111 |
| 5 | SIK1 | 4.04156466 |
| 6 | EPHA2 | 3.53598471 |
| 7 | BCKDK | 3.47236967 |
| 8 | LMTK2 | 3.13416508 |
| 9 | PDK3 | 2.80696345 |
| 10 | PDK4 | 2.80696345 |
| 11 | MST1R | 2.75616609 |
| 12 | NLK | 2.61404593 |
| 13 | RIPK1 | 2.61207932 |
| 14 | CDK12 | 2.27586979 |
| 15 | PRKAA2 | 1.96061858 |
| 16 | STK38L | 1.89461040 |
| 17 | PDK2 | 1.85214101 |
| 18 | FGFR2 | 1.81561978 |
| 19 | FGFR3 | 1.72390007 |
| 20 | MYLK | 1.68049149 |
| 21 | ERN1 | 1.65260740 |
| 22 | EPHA4 | 1.51250529 |
| 23 | INSRR | 1.47191790 |
| 24 | EPHB2 | 1.44845334 |
| 25 | EPHA3 | 1.44498447 |
| 26 | MAP2K2 | 1.40849551 |
| 27 | MELK | 1.39547969 |
| 28 | FRK | 1.38719294 |
| 29 | STK24 | 1.33556752 |
| 30 | PDGFRA | 1.33446870 |
| 31 | TTN | 1.29989113 |
| 32 | TGFBR2 | 1.27995132 |
| 33 | PRKD3 | 1.24704401 |
| 34 | SMG1 | 1.21889253 |
| 35 | PIK3CA | 1.17949363 |
| 36 | CDK9 | 1.14321121 |
| 37 | MAP2K1 | 1.12808118 |
| 38 | MET | 1.12001694 |
| 39 | FER | 1.11405467 |
| 40 | CDK6 | 1.09116087 |
| 41 | MAP3K6 | 1.09052318 |
| 42 | DDR2 | 1.08452946 |
| 43 | RIPK4 | 1.07132869 |
| 44 | JAK1 | 1.05461483 |
| 45 | TAF1 | 1.03911180 |
| 46 | PHKG2 | 1.00426975 |
| 47 | PHKG1 | 1.00426975 |
| 48 | BRD4 | 0.97351303 |
| 49 | TAOK3 | 0.96024160 |
| 50 | NTRK1 | 0.93620866 |
| 51 | MAP3K7 | 0.89641350 |
| 52 | NEK9 | 0.89112709 |
| 53 | PRKAA1 | 0.88045420 |
| 54 | PDPK1 | 0.85046747 |
| 55 | PTK2B | 0.82768223 |
| 56 | LATS1 | 0.82173535 |
| 57 | PINK1 | 0.79827098 |
| 58 | STK3 | 0.76020267 |
| 59 | LATS2 | 0.73961640 |
| 60 | BMPR1B | 0.72157353 |
| 61 | FGFR1 | 0.71375413 |
| 62 | JAK2 | 0.70782311 |
| 63 | TIE1 | 0.70744509 |
| 64 | IGF1R | 0.70540427 |
| 65 | MAP3K3 | 0.70016687 |
| 66 | ILK | 0.66987428 |
| 67 | TRPM7 | 0.66679530 |
| 68 | CAMKK2 | 0.66669463 |
| 69 | PAK2 | 0.65875496 |
| 70 | PRKCH | 0.65580539 |
| 71 | CAMK1 | 0.65543873 |
| 72 | KDR | 0.65246767 |
| 73 | FGFR4 | 0.64255165 |
| 74 | PRKACG | 0.62845053 |
| 75 | IRAK3 | 0.62480620 |
| 76 | RET | 0.61383186 |
| 77 | DAPK2 | 0.60843966 |
| 78 | PDK1 | 0.60186391 |
| 79 | BRSK2 | 0.59199235 |
| 80 | ERBB2 | 0.59124876 |
| 81 | CDK3 | 0.58732252 |
| 82 | CSK | 0.58503235 |
| 83 | GSK3A | 0.55170452 |
| 84 | MAP3K2 | 0.54825526 |
| 85 | MTOR | 0.54611034 |
| 86 | TESK1 | 0.54143458 |
| 87 | EIF2AK2 | 0.52787395 |
| 88 | PDGFRB | 0.51244370 |
| 89 | SRC | 0.51198753 |
| 90 | INSR | 0.50939230 |
| 91 | PRPF4B | 0.48331842 |
| 92 | PRKD1 | 0.47348296 |
| 93 | JAK3 | 0.46836597 |
| 94 | HIPK2 | 0.46669376 |
| 95 | MAPKAPK2 | 0.46560080 |
| 96 | RPS6KA5 | 0.46261219 |
| 97 | FES | 0.44415702 |
| 98 | MAPK7 | 0.43720803 |
| 99 | PRKG2 | 0.41944045 |
| 100 | RPS6KL1 | 0.41539801 |
| 101 | RPS6KC1 | 0.41539801 |
| 102 | ACVR1B | 0.40620020 |
| 103 | MARK2 | 0.38585968 |
| 104 | EPHB1 | 0.37854621 |
| 105 | MAPK15 | 0.37000421 |
| 106 | LRRK2 | 0.36306683 |
| 107 | CSNK1A1 | 0.35990297 |
| 108 | PAK4 | 0.34877338 |
| 109 | PRKCZ | 0.34856993 |
| 110 | BMPR2 | 0.34737030 |
| 111 | SGK2 | 0.33829774 |
| 112 | RPS6KA6 | 0.33827787 |
| 113 | STK38 | 0.33714701 |
| 114 | MAPKAPK3 | 0.33341355 |
| 115 | HCK | 0.33186168 |
| 116 | TYK2 | 0.32203624 |
| 117 | CSNK1G2 | 0.30434334 |
| 118 | FGR | 0.30327113 |
| 119 | MAPK12 | 0.29688924 |
| 120 | RPS6KB1 | 0.28833207 |
| 121 | PRKD2 | 0.28259706 |
| 122 | CLK1 | 0.27068814 |
| 123 | BMX | 0.27066680 |
| 124 | EEF2K | 0.26162981 |
| 125 | ABL1 | 0.26011028 |
| 126 | STK11 | 0.24907358 |
| 127 | RPS6KA2 | 0.24658289 |
| 128 | PKN1 | 0.24388005 |
| 129 | MAPK4 | 0.23903779 |
| 130 | MAPK11 | 0.23894238 |
| 131 | PIK3CG | 0.23823039 |
| 132 | PTK6 | 0.23666287 |
| 133 | SGK3 | 0.23167563 |
| 134 | PTK2 | 0.22927981 |
| 135 | DMPK | 0.22520551 |
| 136 | RPS6KA1 | 0.22328854 |
| 137 | MAP2K3 | 0.21804337 |
| 138 | FYN | 0.21638542 |
| 139 | GRK1 | 0.20907048 |
| 140 | CAMK4 | 0.20802619 |
| 141 | NTRK2 | 0.20481403 |
| 142 | ERBB3 | 0.19589070 |
| 143 | TNK2 | 0.19577299 |
| 144 | CDK5 | 0.18795975 |
| 145 | GRK5 | 0.18705723 |
| 146 | MAPK8 | 0.18163501 |
| 147 | BTK | 0.18005653 |
| 148 | AKT1 | 0.17602389 |
| 149 | ABL2 | 0.17476336 |
| 150 | MAPK3 | 0.17302936 |
| 151 | NEK6 | 0.17207537 |
| 152 | CSF1R | 0.16928963 |
| 153 | CSNK1G1 | 0.15999565 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | * Autoimmune thyroid disease_Homo sapiens_hsa05320 | 6.06491595 |
| 2 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 5.09018225 |
| 3 | * Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 4.60807267 |
| 4 | PPAR signaling pathway_Homo sapiens_hsa03320 | 4.34663464 |
| 5 | Propanoate metabolism_Homo sapiens_hsa00640 | 4.23104509 |
| 6 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 3.36124179 |
| 7 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 3.21864227 |
| 8 | Fatty acid metabolism_Homo sapiens_hsa01212 | 3.08260371 |
| 9 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 2.82119233 |
| 10 | Fatty acid degradation_Homo sapiens_hsa00071 | 2.24355862 |
| 11 | Pyruvate metabolism_Homo sapiens_hsa00620 | 2.19548796 |
| 12 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 2.17783734 |
| 13 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 2.14942240 |
| 14 | AMPK signaling pathway_Homo sapiens_hsa04152 | 2.10213130 |
| 15 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.95938006 |
| 16 | Fat digestion and absorption_Homo sapiens_hsa04975 | 1.79853750 |
| 17 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.79763049 |
| 18 | Tyrosine metabolism_Homo sapiens_hsa00350 | 1.73571443 |
| 19 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 1.60557259 |
| 20 | Nitrogen metabolism_Homo sapiens_hsa00910 | 1.56096948 |
| 21 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 1.53920368 |
| 22 | Carbon metabolism_Homo sapiens_hsa01200 | 1.39673765 |
| 23 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 1.33489889 |
| 24 | Peroxisome_Homo sapiens_hsa04146 | 1.29712870 |
| 25 | Insulin signaling pathway_Homo sapiens_hsa04910 | 1.29292622 |
| 26 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 1.26891422 |
| 27 | Renin secretion_Homo sapiens_hsa04924 | 1.24600673 |
| 28 | Insulin resistance_Homo sapiens_hsa04931 | 1.24410217 |
| 29 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.18761900 |
| 30 | ECM-receptor interaction_Homo sapiens_hsa04512 | 1.17734302 |
| 31 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 1.16808153 |
| 32 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 1.11504537 |
| 33 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 1.10476761 |
| 34 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 1.04928494 |
| 35 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 1.03002115 |
| 36 | Lysine degradation_Homo sapiens_hsa00310 | 1.02137070 |
| 37 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 1.00140726 |
| 38 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.99670756 |
| 39 | Circadian rhythm_Homo sapiens_hsa04710 | 0.96961163 |
| 40 | Butanoate metabolism_Homo sapiens_hsa00650 | 0.96738808 |
| 41 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.96403117 |
| 42 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.93320320 |
| 43 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.91198765 |
| 44 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.89894007 |
| 45 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.88843135 |
| 46 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.88408537 |
| 47 | Endometrial cancer_Homo sapiens_hsa05213 | 0.87015307 |
| 48 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.86809697 |
| 49 | Other glycan degradation_Homo sapiens_hsa00511 | 0.74638851 |
| 50 | Protein digestion and absorption_Homo sapiens_hsa04974 | 0.73625815 |
| 51 | Focal adhesion_Homo sapiens_hsa04510 | 0.73004100 |
| 52 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.71389938 |
| 53 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 0.69969365 |
| 54 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.69408008 |
| 55 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 0.68759167 |
| 56 | ABC transporters_Homo sapiens_hsa02010 | 0.68156699 |
| 57 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 0.68008087 |
| 58 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 0.62501391 |
| 59 | Fatty acid elongation_Homo sapiens_hsa00062 | 0.62477254 |
| 60 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 0.60807661 |
| 61 | Amoebiasis_Homo sapiens_hsa05146 | 0.59859027 |
| 62 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.59768266 |
| 63 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.58575399 |
| 64 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.57250614 |
| 65 | Salivary secretion_Homo sapiens_hsa04970 | 0.55861955 |
| 66 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.55073820 |
| 67 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.54067542 |
| 68 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.52780580 |
| 69 | Lysosome_Homo sapiens_hsa04142 | 0.52229216 |
| 70 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.51043752 |
| 71 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.49151154 |
| 72 | Prostate cancer_Homo sapiens_hsa05215 | 0.48978230 |
| 73 | Melanoma_Homo sapiens_hsa05218 | 0.48741563 |
| 74 | Hippo signaling pathway_Homo sapiens_hsa04390 | 0.48388943 |
| 75 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 0.48135081 |
| 76 | Tryptophan metabolism_Homo sapiens_hsa00380 | 0.48073700 |
| 77 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.47745162 |
| 78 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.46767989 |
| 79 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.45404097 |
| 80 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 0.45043682 |
| 81 | Colorectal cancer_Homo sapiens_hsa05210 | 0.44624399 |
| 82 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 0.44194115 |
| 83 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 0.42719023 |
| 84 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.40734367 |
| 85 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.40420077 |
| 86 | Basal cell carcinoma_Homo sapiens_hsa05217 | 0.38712750 |
| 87 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.37589398 |
| 88 | Tight junction_Homo sapiens_hsa04530 | 0.36477542 |
| 89 | * cAMP signaling pathway_Homo sapiens_hsa04024 | 0.35263004 |
| 90 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.34977502 |
| 91 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 0.34742126 |
| 92 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.34618673 |
| 93 | Arginine biosynthesis_Homo sapiens_hsa00220 | 0.34597969 |
| 94 | TGF-beta signaling pathway_Homo sapiens_hsa04350 | 0.34490182 |
| 95 | Toxoplasmosis_Homo sapiens_hsa05145 | 0.34145958 |
| 96 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.32885753 |
| 97 | Signaling pathways regulating pluripotency of stem cells_Homo sapiens_hsa04550 | 0.32479135 |
| 98 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.32224185 |
| 99 | Bladder cancer_Homo sapiens_hsa05219 | 0.31736546 |
| 100 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.30907923 |
| 101 | * Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.30865412 |
| 102 | Gastric acid secretion_Homo sapiens_hsa04971 | 0.30397807 |
| 103 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.30382169 |
| 104 | Long-term potentiation_Homo sapiens_hsa04720 | 0.29874739 |
| 105 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.29405869 |
| 106 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.29109097 |
| 107 | PI3K-Akt signaling pathway_Homo sapiens_hsa04151 | 0.28957819 |
| 108 | Pathways in cancer_Homo sapiens_hsa05200 | 0.28834306 |
| 109 | Cholinergic synapse_Homo sapiens_hsa04725 | 0.28335940 |
| 110 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.28072858 |
| 111 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.27654975 |
| 112 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.26830577 |
| 113 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 0.26431596 |
| 114 | Viral myocarditis_Homo sapiens_hsa05416 | 0.25624911 |
| 115 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 0.25112484 |
| 116 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 0.24319462 |
| 117 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.24132213 |
| 118 | Osteoclast differentiation_Homo sapiens_hsa04380 | 0.23858727 |
| 119 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.23771639 |
| 120 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 0.23627937 |
| 121 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.23406550 |
| 122 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.22776265 |
| 123 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.22663802 |
| 124 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.22648981 |
| 125 | Pertussis_Homo sapiens_hsa05133 | 0.21131601 |
| 126 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.20844926 |
| 127 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.20736857 |
| 128 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 0.20731955 |
| 129 | Histidine metabolism_Homo sapiens_hsa00340 | 0.20542364 |
| 130 | Platelet activation_Homo sapiens_hsa04611 | 0.20274132 |
| 131 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.20041017 |
| 132 | Hepatitis C_Homo sapiens_hsa05160 | 0.19522561 |
| 133 | Taste transduction_Homo sapiens_hsa04742 | 0.19431923 |
| 134 | Adherens junction_Homo sapiens_hsa04520 | 0.19425094 |
| 135 | Malaria_Homo sapiens_hsa05144 | 0.17946361 |
| 136 | Cocaine addiction_Homo sapiens_hsa05030 | 0.17318421 |
| 137 | Glioma_Homo sapiens_hsa05214 | 0.17222513 |
| 138 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.16909724 |
| 139 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.15702264 |
| 140 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.15269417 |
| 141 | Hedgehog signaling pathway_Homo sapiens_hsa04340 | 0.14627893 |
| 142 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 0.14299761 |
| 143 | Melanogenesis_Homo sapiens_hsa04916 | 0.12889882 |
| 144 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.12560317 |
| 145 | Retinol metabolism_Homo sapiens_hsa00830 | 0.12075974 |
| 146 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 0.11976730 |
| 147 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.11731577 |
| 148 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.11698194 |
| 149 | Thyroid cancer_Homo sapiens_hsa05216 | 0.11516247 |
| 150 | Tuberculosis_Homo sapiens_hsa05152 | 0.11230605 |
| 151 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 0.10875282 |
| 152 | Bile secretion_Homo sapiens_hsa04976 | 0.10552350 |

